Eli Lilly and company

Eli Lilly Gets Emergency Use Permit For Antibody Drugs To Treat COVID-19 Patients In India

Bamlanivimab and etesevimab combined can be given to adults and paediatric patients (12 years and older of at least 40 kg weight) in a restricted manner via injections. Mild and moderate cases of COVID-19 can be treated with the drug.